St. Jude Medical announces FDA approval of the Infinity DBS system with directional lead technology designed to help patients with Parkinson’s disease ...

Medtronic's SenSight DBS system combines steering capability with next-generation brain sensing capability to more precisely target motor symptoms in patients with movement disorders.

Medtronic plc MDT recently announced receipt of the FDA’s approval for its Percept PC Deep Brain Stimulation (“DBS”) system. The inclusion of the BrainSense technology with the Percept PC ...

Abbott's Liberta RC DBS system, the world's smallest FDA-approved rechargeable deep brain stimulation device. With only 10 recharges a year, it's compatible with NeuroSphere Virtual Clinic ...

Medtronic plc MDT received the CE Mark for its SenSight directional lead for the treatment of system symptoms associated with movement disorders and epilepsy. SenSight is currently the only ...

The U.S. FDA recently granted Medtronic plc approval for its deep brain stimulation (DBS) system to be used to treat Parkinson’s disease or essential tremor while a patient is asleep, under general ...

Boston Scientific Corporation BSX has received CE Mark approval for use of the GUIDE™ DBS System, the world's first deep brain stimulation (DBS) visualization system.